PMID- 24548738 OWN - NLM STAT- MEDLINE DCOM- 20160413 LR - 20140619 IS - 1742-1241 (Electronic) IS - 1368-5031 (Linking) VI - 68 IP - 7 DP - 2014 Jul TI - Risk factors associated with retinal vein occlusion. PG - 871-81 LID - 10.1111/ijcp.12390 [doi] AB - AIMS: Retinal vein occlusion (RVO) is the most frequent retinal vascular disease after diabetic retinopathy in which arterial risk factors are much more relevant than venous factors. The objective was to evaluate the role of risk factors in the development of the first episode of RVO. SUBJECTS AND METHODS: One hundred patients with RVO [mean age 56 years, 42% females and mean body mass index (BMI) 27.5 kg/m(2)] were recruited consecutively from the outpatient clinic of a tertiary hospital in Valencia (Spain). All subjects underwent clinical assessment including anthropometric and blood pressure measurements and laboratory test including homocysteine, antiphospholipid antibodies (aPLAs) and thrombophilia studies. In half of the subjects, a carotid ultrasonography was performed. Three control populations matched by age, sex and BMI from different population-based studies were used to compare the levels and prevalence of arterial risk factors. One cohort of young patients with venous thromboembolic disease was used to compare the venous risk factors. RESULTS: Blood pressure levels and the prevalence of hypertension were significantly higher in the RVO population when compared with those for the general populations. There was also a large proportion of undiagnosed hypertension within the RVO group. Moreover, carotid evaluation revealed that a large proportion of patients with RVO had evidence of subclinical organ damage. In addition, homocysteine levels and prevalence of aPLAs were similar to the results obtained in our cohort of venous thromboembolic disease. CONCLUSIONS: The results indicate that hypertension is the key factor in the development of RVO, and that RVO can be the first manifestation of an undiagnosed hypertension. Furthermore, the majority of these patients had evidence of atherosclerotic disease. Among the venous factors, a thrombophilia study does not seem to be useful and only the prevalence of hyperhomocysteinaemia and aPLAs is higher than in the general population. CI - (c) 2014 John Wiley & Sons Ltd. FAU - Martinez, F AU - Martinez F AD - Internal Medicine Department, Fundacion de Investigacion del Hospital Clinico de Valencia- INCLIVA, Hospital Clinico Universitario, Universidad de Valencia, Valencia, Spain; "Centro de Investigacion Biomedica en Red (CIBER) de Fisiopatologia, Obesidad y Nutricion (CIBEROB)", Institute of Health Carlos III, Minister of Health, Madrid, Spain. FAU - Furio, E AU - Furio E FAU - Fabia, M J AU - Fabia MJ FAU - Perez, A V AU - Perez AV FAU - Gonzalez-Albert, V AU - Gonzalez-Albert V FAU - Rojo-Martinez, G AU - Rojo-Martinez G FAU - Martinez-Larrad, M T AU - Martinez-Larrad MT FAU - Mena-Martin, F J AU - Mena-Martin FJ FAU - Soriguer, F AU - Soriguer F FAU - Serrano-Rios, M AU - Serrano-Rios M FAU - Chaves, F J AU - Chaves FJ FAU - Martin-Escudero, J C AU - Martin-Escudero JC FAU - Redon, J AU - Redon J FAU - Garcia-Fuster, M J AU - Garcia-Fuster MJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140218 PL - India TA - Int J Clin Pract JT - International journal of clinical practice JID - 9712381 SB - IM MH - Adult MH - Aged MH - Dyslipidemias/complications MH - Female MH - Humans MH - Hypertension/complications MH - Male MH - Middle Aged MH - Obesity/complications MH - *Prevalence MH - Retinal Vein Occlusion/*epidemiology/etiology MH - Risk Factors MH - Spain MH - Thrombophilia/complications EDAT- 2014/02/20 06:00 MHDA- 2016/04/14 06:00 CRDT- 2014/02/20 06:00 PHST- 2014/02/20 06:00 [entrez] PHST- 2014/02/20 06:00 [pubmed] PHST- 2016/04/14 06:00 [medline] AID - 10.1111/ijcp.12390 [doi] PST - ppublish SO - Int J Clin Pract. 2014 Jul;68(7):871-81. doi: 10.1111/ijcp.12390. Epub 2014 Feb 18.